In vitro Pharmacological Evaluation of Herbal Tea for the Treatment of Urolithiasis
Article Sidebar
Main Article Content
Abstract
Urolithiasis arises from the precipitation and crystallization of stone-forming minerals in the kidneys due to urine supersaturation. Calcium oxalate are the most prevalent among the stone-forming minerals. In Ayurveda, herbal remedies have been used in the treatment of urolithiasis. This study aimed to evaluate herbal tea extracts of Trigonella foenum-graecum L. leaves, Mimosa pudica L. leaves, and Zea mays L. silk for their anti-urolithiatic activity in vitro. Three formulations of herbal tea bag of the combination of Trigonella foenum-graecum Leaves, Mimosa pudica Leaves, and Zea mays silk were prepared in the following proportions; 50:25:25 (formulation 1), 25:50:25 (formulation 2), and 25:25:50 (formulation 3). Calcium oxalate crystals were precipitated by reaction between calcium chloride and sodium oxalate. The anti-urolithiatic effect of the herbal tea formulations was investigated via the nucleation and aggregation assays. The drug cystone was used as the standard. The calcium oxalate crystals in both assays were examined microscopically to determine their sizes, shapes and quantities. Results showed that the three herbal tea formulations exhibited significant (p < 0.05) inhibition of calcium oxalate crystal both in the nucleation and aggregation assays. The highest anti-urolithiatic effect was observed at 1.0 mg/mL for tea bag formulation 1, with percentage inhibition of 94.89%, and 81.45% in the nucleation and aggregation assays, respectively. Microscopic examination revealed a reduction of calcium oxalate crystals in the test samples compared to the control. This study has demonstrated the efficacy of herbal tea in dissolving calcium oxalate crystals and reducing stone formation, indicating its promising anti-urolithiasis activity.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
1. Sultan S, Umer SA, Ahmed B. Urolithiasis. In: godbole P, Wilcox D, Koyle MA (Eds), Practical Pediatric Urology: An Evidence-Based Approach. Springer, 2023. 377–403 p.
2. Yousefichaijan P, Azami M, Ranjbaran M, Azami S, Rahmati S. Clinical Signs, Causes, and Risk Factors of Pediatric Kidney Stone Disease: A Hospital-Based Case-Control Study. Nephrourol Mon. 2017; 9(1):1-5.
3. Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, Zeng G. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018; 5(4):205–214.
4. Perumal KR, Chua RHB, Teh GC, Lei CCM. Prevalence of urolithiasis in Sarawak and associated risk factors: An ultrasonagraphy‐based cross‐sectional study. BJUI Compass. 2023; 4(1):74–80.
5. Nouri AI and Hassali MA. Assessment of kidney stone disease prevalence in a teaching hospital. Afr J Urol. 2018; 24(3):180–185.
6. Vijaya T, Sathish Kumar M, Ramarao NV, Naredra Babu A, Ramarao N. Urolithiasis and Its Causes-Short Review. The J Phytopharmacol. 2013; 2(3):1–6.
7. Huang Y, Zhang YH, Chi ZP, Huang R, Huang H, Liu GY, Zhang Y, Yang H, Lin J, Yang T, Cao SZ. The Handling of Oxalate in the Body and the Origin of Oxalate in Calcium Oxalate Stones. Urol Int. 2020; 104(3–4):167–176.
8. Kasote DM, Jagtap SD, Thapa D, Khyade MS, Russell WR. Herbal remedies for urinary stones used in India and China: A review. J Ethnopharmacol. 2017; 203:55–68.
9. Kant R, Singh TG, Singh S. Mechanistic approach to herbal formulations used for urolithiasis treatment. Obes Med. 2020; 19:100266.
10. Ahmed S, Hasan MM, Mahmood ZA, Muhammad C, Hasan M, Mahmood A. Antiurolithiatic plants in different countries and cultures. J Pharmacogn Phytochem. 2016; 5(1):102–115.
11. Hinad I, S’hih Y, Elgui R, Mesfioui A, Elhessni A, Ouahidi ML. Acute and Subacute Toxicity Study of Trigonella foenum-graecum.L Seed Extract in Wistar Rat. Trop J Nat Prod Res. 2023; 7(10):4912-4915
12. Chatterjee S, Ghosh B, Chandra I. Fenugreek (Trigonella foenum gracum L.) and its necessity (A Review Paper Fenugreek (Trigonella foenum-graecum L.) and its necessity [Review Paper]. Fire J Eng Technol. 2015; 1(1):60-67.
13. Majeed I, Rizwan K, Ashar A, Rasheed T, Amarowicz R, Kausar H, Zia-Ul-Haq M, Marceanu LG. A Comprehensive Review of the Ethnotraditional Uses and Biological and Pharmacological Potential of the Genus mimosa. Int J Mol Sci. 2021; 22(14):7463.
14. Zahid IH, Bawazir AS, Naser R. Plant based native therapy for the treatment of Kidney stones in Aurangabad (M.S). J Pharmacogn Phytochem. 2013;1(6):189–193.
15. Tian S, Sun Y, Chen Z. Extraction of Flavonoids from Corn Silk and Biological Activities In Vitro. J Food Qual. 2021; 2021:1–9.
16. Revilla P, Alves ML, Andelković V, Balconi C, Dinis I, Mendes-Moreira P, Redaelli R, Ruiz de Galarreta JI, Vaz Patto MC, Žilić S, Malvar RA. Traditional Foods From Maize (Zea mays L.) in Europe. Front Nutr. 2021; 8:683399.
17. Wang H, Shi S, Wang S. Can highly cited herbs in ancient Traditional Chinese medicine formulas and modern publications predict therapeutic targets for diabetes mellitus? J Ethnopharmacol. 2018; 213:101–110.
18. Okokon JE, Nyong ME, Thomas PS, Daniel AO, Enin GN, Udobang JA. Antiobesity Activity of Extract, Fractions and Pure Compounds from Husk of Zea mays. Trop J Nat Prod Res. 2021; 5(10):1868–1875.
19. Middha SK, Usha T, Tripathi P, Marathe KY, Jain T, Bhatt B, Masurkar YP, Pande V. An in vitro studies on indigenous ayurvedic plants, having hypoglycemic activity. Asian Pac J Trop Dis. 2012; 2(SUPPL.1):S46–S49.
20. Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: Concept of ayurveda. Pharmacogn Rev. 2014; 8(16):73.
21. Senthil Kumari C and Logeshwari B. In silico and In vitro Evaluation of Anti-Urolithiatic Activity of Ethanolic Extract of Hybanthus enneaspermus (Linn.) F. Muell. Int J Pharm Res Applic. 2021; 6(2):548-560.
22. Butterweck V and Khan SR. Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med. 2009; 75(10):1095–1103.
23. Vekilov PG. Nucleation. Cryst Growth Des. 2010; 10(12):5007–5019.
24. Della Vecchia NF, Luchini A, Napolitano A, D’Errico G, Vitiello G, Szekely N, d’Ischia M, Paduano L. Tris Buffer Modulates Polydopamine Growth, Aggregation, and Paramagnetic Properties. Langmuir. 2014; 30(32):9811–9818.
25. Alelign T and Petros B. Kidney Stone Disease: An Update on Current Concepts. Adv Urol. 2018; 2018:1–12.
26. Hewagama SP and Hewawasam RP. Antiurolithiatic Potential of Three Sri Lankan Medicinal Plants by the Inhibition of Nucleation, Growth, and Aggregation of Calcium Oxalate Crystals In Vitro. The Sci World J. 2022; 2022:1–13.
27. Singh N, Yadav SS, Kumar S, Narashiman B. Ethnopharmacological, phytochemical and clinical studies on Fenugreek (Trigonella foenum-graecum L.). Food Biosci. 2022; 46:101546.
28. Ma ZN, Li YZ, Li W, Yan XT, Yang G, Zhang J, Zhao LC, Yang LM. Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury. Int J Mol Sci. 2017; 18(7):1407.
29. Ahmed S, Hasan MM, Khan H, Mahmood ZA, Patel S. The mechanistic insight of polyphenols in calcium oxalate urolithiasis mitigation. Biomedicine & Pharmacotherapy. 2018; 106:1292–1299.
30. Rashid S, Sameti M, Alqarni MH, Abdel Bar FM. In vivo investigation of the inhibitory effect of Peganum harmala L. and its major alkaloids on ethylene glycol-induced urolithiasis in rats. J Ethnopharmacol. 2023; 300:115752.
31. Sorensen MD, Hsi RS, Chi T, Shara N, Wactawski-Wende J, Kahn AJ, Wang H, Hou L, Stoller ML, Women’s Health Initiative Writing Group. Dietary Intake of Fiber, Fruit and Vegetables Decreases the Risk of Incident Kidney Stones in Women: A Women’s Health Initiative Report. J Urol. 2014;192(6):1694–1699.
32. Nunes CDR, Barreto Arantes M, Menezes de Faria Pereira S, Leandro da Cruz L, de Souza Passos M, Pereira de Moraes L, Vieira IJC, Barros de Oliveira D. Plants as Sources of Anti-Inflammatory Agents. Molecules. 2020; 25(16):3726.
33. Golkar P, Allafchian A, Afshar B. Alyssum lepidium mucilage as a new source for electrospinning: production and physicochemical characterisation. IET Nanobiotechnol. 2018; 12(3):259–263.
34. Patil AG, Prakash JK, More SS, Chandramohan V, Zameer F. Exploring Banana phytosterols (Beta-sitosterol) on tight junction protein (claudin) as anti-urolithiasis contributor in Drosophila: A phyto-lithomic approach. Inform Med Unlocked. 2022; 29:100905.
35. Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN. Dietary Protein and Potassium, Diet–Dependent Net Acid Load, and Risk of Incident Kidney Stones. Clin J Am Soc Nephrol. 2016; 11(10):1834–1844.
36. Han H, Segal AM, Seifter JL, Dwyer JT. Nutritional Management of Kidney Stones (Nephrolithiasis). Clin Nutr Res. 2015; 4(3):137.
37. Bargagli M, Ferraro PM, Vittori M, Lombardi G, Gambaro G, Somani B. Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review. Nutrients. 2021; 13(12):4363.
38. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. Am J Kidney Dis. 2016; 67(3):400–407.
39. Lakshmibai R. Preliminary Phytochemical Analysis and Antioxidant Activities of Prosopis Juliflora and Mimosa Pudica Leaves. Int J Sci Eng Technol Res. 2015; 4(30):5766–5770.
40. Zeng X, Xi Y, Jiang W. Protective roles of flavonoids and flavonoid-rich plant extracts against urolithiasis: A review. Crit Rev Food Sci Nutr. 2019; 59(13):2125–2135.
41. Al-Mamoori F and Aburjai T. Perspective Chapter: Medicinal Plants for the Treatment of Nephrolithiasis. In: Nephrolithiasis - From Bench to Bedside. IntechOpen; 2023. Available from: http://dx.doi.org/10.5772/intechopen.108495
42. Madeo J, Zubair A, Marianne F. A review on the role of quinones in renal disorders. Springerplus. 2013; 2(1):139.
43. Zou GJ, Huang WB, Sun XY, Tang GH, Ouyang JM. Carboxymethylation of Corn Silk Polysaccharide and Its Inhibition on Adhesion of Nanocalcium Oxalate Crystals to Damaged Renal Epithelial Cells. ACS Biomater Sci Eng. 2021; 7(7):3409–3422.
44. Naga Kishore R. Investigation of Anti-Urolithiatic Activity of Linum usitatissimum and Mimosa pudica in Experimentally Induced Urolithiasis in Animal Models. Kishore World J Pharm Res. 2018; 7(1):1086-1092.
45. Bhandari R, Panta A, Panth P, Aryal D, Gautam U, Joshi DR, Kumar R, Rokaya TB, Pandey J, Aryal P. In-vitro Comparison of Anti-urolithiatic Effect of Crataeva nurvala, Zea mays (Corn Silk) and Ayurvedic Formulation Neeri Tablet. Int J Pharm Sci Rev Res. 2023; 66(1):26–30.
46. Khoo LW, Audrey Kow S, Lee MT, Tan CP, Shaari K, Tham CL, Abas F. A Comprehensive Review on Phytochemistry and Pharmacological Activities of Clinacanthus nutans (Burm.f.) Lindau. Evid Based Complement Alternat Med. 2018;2018:9276260.